SAN FRANCISCO, June 5, 2025 /PRNewswire/ -- A securities class action lawsuit styled Cockrell v. UroGen Pharma Ltd. et al., No. 3:25-cv-06088 (D. N.J.) has been filed and seeks to represent investors who purchased or otherwise acquired UroGen securities between July 27, 2023 and May 15,...
Read More Details
Finally We wish PressBee provided you with enough information of ( UroGen Pharma Ltd. (URGN) Faces Securities Class Action Amid FDA's Briefing Document and Subsequent ODAC Vote Against UGN-102- Hagens Berman )
Also on site :
- Amazon Has ‘Awesome’ $30 Arch Support Flip Flops on Sale for $12, and Reviewers Are ‘Stunned’ How Comfortable They Are
- Today’s NYT ‘Strands’ Hints, Spangram and Answers for Saturday, June 7
- Column: Adoption days are here at Pasadena Humane